Results for Drug Benefits and Risk

In this research news roundup, new insights from the HERO registry, a targeted treatment for high-risk relapsed B-ALL, and more.

Nominated by their Centers of Emphasis, women in STEM share what drives them, their words of wisdom, and why they do what they do.

CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.

Learn about the research projects supported by CPCE/PolicyLab Pilot Grants and how they seek to drive change in policy and practice.

This week’s roundup features research exploring the value of well care as voiced by Black adolescent males and their parents. This and more In The News.

Researchers published the first report of pediatric patients treated with convalescent plasma for SARS-CoV-2 associated acute respiratory distress syndrome.

Researchers at CHOP found that dexrazoxane lowers risk for cardiotoxicity associated with chemotherapy in pediatric AML

David Teachey, MD, and colleagues are exploring convalescent plasma as a treatment for COVID-19, the disease caused by SARS-CoV-2.

Options to ship study drugs during COVID-19

In the News announces the Research Institute’s 2019 Annual Report and shares research highlights to start off the holiday season.